- Home
- DLNG vs MCRB Comparison
DLNG vs MCRB Comparison
Compare DLNG & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DLNG | MCRB |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.3M | 85.7M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | DLNG | MCRB |
|---|---|---|
| Price | $3.89 | $7.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 73.1K | 46.5K |
| Earning Date | 05-26-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | N/A | ★ $789,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.10 | N/A |
| P/E Ratio | ★ $3.04 | $10.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.31 | $6.56 |
| 52 Week High | $4.45 | $29.98 |
Technical Indicators
Market Signals| Indicator | DLNG | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 36.26 |
| Support Level | $3.79 | N/A |
| Resistance Level | $4.25 | $9.53 |
| Average True Range (ATR) | 0.12 | 0.58 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 11.11 | 36.43 |
Price Performance
Historical ComparisonAbout DLNG Dynagas LNG Partners LP
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and is winterized, which enables trade in subzero and ice bound conditions.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.